[Cancer of therapeutic origin].
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects; D003494:Cyclamates / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D012739:Gonadal Steroid Hormones / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008297:Male; D051379:Mice; D009369:Neoplasms / Q000139:chemically induced* / Q000209:etiology; D009381:Neoplasms, Radiation-Induced; D010615:Phenacetin / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D014184:Transplantation, Homologous / Q000009:adverse effects
D000970:Antineoplastic Agents; D003494:Cyclamates; D012739:Gonadal Steroid Hormones; D007166:Immunosuppressive Agents; D010615:Phenacetin; D010653:Phenylbutazone
Les cancers d'origine thérapeutique.